Contraindicated. Coadministration of doravirine with a robust CYP3A inducer might lessen doravirine plasma concentrations and/or effects. Possible for lack of virologic reaction and achievable resistance to doravirine.pentobarbital will lessen the extent or effect of meloxicam by affecting hepatic enzyme CYP2C9/ten metabolism. Minimal/Significance